Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, treatable immune-mediated disease in which the body attacks the covering of the peripheral nerves, causing weakness, numbness and tingling that develop over weeks to months. It needs treatment directed by a neurologist. At Netra Integrative Health Clinic in South Plainfield, NJ, acupuncture, Ayurvedic medicine and herbal medicine are offered only as supportive care for symptoms, alongside your medical treatment.

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
At a glance
  • What it is: A rare immune-mediated disorder of the peripheral nerves and nerve roots in which the myelin covering is damaged, slowing or blocking nerve signals.
  • Common symptoms: Weakness in the arms and legs, numbness and tingling, loss of reflexes, tiredness and sometimes nerve pain, developing over at least 8 weeks.
  • Conventional care: Intravenous or subcutaneous immunoglobulin, corticosteroids or plasma exchange, with other immune-calming drugs and rehabilitation, directed by a neurologist.
  • How integrative care fits: Supportive care for nerve pain, tiredness, sleep, stress and treatment side effects, only with your treating team's knowledge.
  • Evidence at a glance: No studies of acupuncture, Ayurveda or herbs in CIDP were found; research exists only for related symptoms such as neuropathic pain, fatigue and sleep.

What is Chronic Inflammatory Demyelinating Polyneuropathy?

Chronic inflammatory demyelinating polyneuropathy, also called chronic inflammatory demyelinating polyradiculoneuropathy, is an immune-mediated disorder of the peripheral nerves and nerve roots. The immune system damages myelin, the insulating layer around nerve fibers, so signals travel more slowly or are blocked.[1] It is rare, with a pooled estimate of about 3 cases per 100,000 people.[2]

CIDP is closely related to acute inflammatory demyelinating polyneuropathy, the demyelinating form of Guillain-Barré syndrome. The two are told apart mainly by timing: CIDP symptoms last at least 8 weeks, and the disease can progress steadily or relapse.[1] CIDP is not simply a long-lasting Guillain-Barré syndrome.

Common symptoms

Typical CIDP causes weakness on both sides of the body, in both upper and lower parts of the limbs, along with sensory loss that affects position and vibration sense more than pain and temperature.[1]

  • Weakness in the legs and arms, which can make stairs, walking or gripping hard
  • Numbness, tingling or reduced feeling in the hands and feet
  • Reduced or absent reflexes
  • Tiredness that is out of proportion to activity
  • Nerve pain in some people

The course may be steady, relapsing or progressive.[1] Several variants exist, including forms that mainly affect one area, the sensory nerves or the motor nerves.[3]

Causes and risk factors

The cause is not known. CIDP is considered immune-mediated, and some people who respond poorly to treatment have antibodies against proteins at the nodes of the nerve.[4] A specific trigger such as an infection or vaccination has been suggested in some reports, but no trigger can be identified in most people, and none can be named as the cause in an individual.

How it is diagnosed and treated conventionally

Diagnosis is made by neurologists from the pattern of symptoms, nerve conduction studies that show demyelination, and the response to immune treatment.[1] Nerve conduction studies are essential, and their poor performance or misinterpretation is a common reason for misdiagnosis.[4] A spinal fluid test and blood tests may add information.

European guidelines recommend intravenous immunoglobulin (IVIg) or corticosteroids as initial treatment, with plasma exchange if those fail. For long-term maintenance they recommend IVIg, subcutaneous immunoglobulin or corticosteroids, with an immune-suppressing drug added if high doses are needed. If pain is present, they advise considering nerve pain medicines and multidisciplinary management.[3]

CIDP is treatable, but maintenance treatment is often needed for years, and the regimen needs regular adjustment to avoid under- or over-treatment.[4]

Why Chronic Inflammatory Demyelinating Polyneuropathy calls for a whole-person approach

CIDP is an immune disease of the nerves that needs specialist care. Alongside it, people often live with weakness, nerve pain, tiredness, balance problems, poor sleep and the effects of long-term treatment.

Supportive care can address some of these symptoms. It does not treat the immune attack on the nerves.

Nerve damage and weakness

Weakness and sensory loss affect movement and daily activity. Structured exercise has been studied for this. A systematic review of 13 studies (173 people, 37 of them with CIDP) found that supervised, individualized multicomponent exercise programs appeared to improve fatigue and functional capacity in Guillain-Barré syndrome and CIDP, although the study designs varied.[5]

Nerve pain

Nerve pain occurs in some people with CIDP, and guidelines advise considering nerve pain medicines and multidisciplinary management.[3]

Fatigue

Fatigue is common in peripheral neuropathy. A Cochrane review found only three trials of treatments for fatigue in neuropathy, none in CIDP, and no evidence for other interventions.[6]

Treatment side effects

Long courses of corticosteroids carry a risk of bone thinning, and guidelines advise assessing fracture risk soon after starting steroids.[7] Side effects are a main reason to coordinate any supportive care with your prescribers.

Acupuncture as supportive care in Chronic Inflammatory Demyelinating Polyneuropathy

What the research shows

No clinical trials of acupuncture in CIDP were found in PubMed. The evidence below concerns related symptoms in other patient groups and cannot be assumed to apply to CIDP. Acupuncture does not treat the immune process.

For nerve pain in general, a Cochrane review of 6 trials (462 people) found the evidence to be very low quality and insufficient to support or refute acupuncture for neuropathic pain. The trials were small and at high risk of bias.[8] A review of 15 studies of neuropathy from several causes found that most randomized trials showed benefit in diabetic neuropathy, Bell's palsy and carpal tunnel syndrome, but there was insufficient evidence for idiopathic neuropathy, and the authors said better-designed trials with sham controls were needed.[9] A meta-analysis of 25 trials (1,561 people) found that acupuncture added to conventional treatment eased pain in painful diabetic neuropathy more than conventional treatment alone, with limitations that call for further studies.[10]

For fatigue, a meta-analysis of 16 studies of chronic fatigue syndrome (not CIDP) found a favorable effect of acupuncture over sham, but the studies were mostly low quality, and no firm conclusion was possible.[11] A meta-analysis of 24 trials in insomnia found acupuncture improved sleep scores compared with medication, with benefit seen after about three weeks, though the trials differed widely from one another.[12]

How acupuncture may work

A review of laboratory and clinical research proposes that acupuncture acts through the nervous, hormonal and immune systems together. The authors describe this as a hypothesis, and it has not been shown to change the course of CIDP.[13]

What treatment involves

Treatment uses fine, sterile, single-use needles, usually left in place for about 20 to 40 minutes, with a short course of visits and reassessment. We would aim treatment at comfort, sleep and stress rather than the disease.

In prospective studies, about 9 in 100 patients had a minor reaction such as soreness, bleeding or bruising at a needle site, and serious events occurred in about 1 in 10,000 patients.[14] Tell the practitioner first if you take immune-suppressing medicine, since infection risk matters, and if you have a bleeding disorder, take blood thinners, are pregnant, or have a pacemaker. Numb areas may not feel needling in the usual way, so tell the practitioner where your sensation is reduced.

Ayurvedic medicine as supportive care in Chronic Inflammatory Demyelinating Polyneuropathy

The Ayurvedic view

Ayurveda has no classical name for CIDP. Weakness, numbness and tingling are traditionally described as Vata disorders, since Vata is the principle said to govern movement and the nervous system. These are traditional categories, not biomedical diagnoses.

Therapies that may be used

In a supportive role, care is chosen for the individual and may include:

  • Diet and daily routine intended to calm Vata, such as warm, regular meals and steady sleep hours
  • Gentle warm oil massage, with care over numb skin because reduced sensation can hide burns from heat
  • Breathing and relaxation practices
  • Herbs such as ashwagandha or turmeric, prescribed individually after review of your medicines

Panchakarma cleansing procedures are not appropriate during pregnancy, acute illness or frailty. They are also generally unsuitable during relapses, with significant weakness, or while taking immune-suppressing medicine, unless your neurologist agrees.

What the research shows

No Ayurvedic studies in CIDP were found, so there is no evidence of benefit for the disease. For related symptoms, a meta-analysis of 9 trials (558 people) found ashwagandha extracts lowered stress and anxiety scores and blood cortisol compared with placebo. Four trials reported mild to moderate adverse events, and long-term safety is not established.[15] These trials were not in people with neuropathy. Turmeric has been tested for nerve symptoms in only one clinical trial in other neuropathies.[16]

Herbal medicine as supportive care in Chronic Inflammatory Demyelinating Polyneuropathy

Herbs and formulas that have been studied

No herbs or formulas have been tested in CIDP. A review of 22 clinical studies of plant-derived medicines in other neuropathies, such as diabetic and chemotherapy-related, found the most evidence for cannabis, linseed oil, capsaicin applied to the skin and a Japanese formula called Goshajinkigan. Chamomile, turmeric and colocynth each had only one trial.[16]

Transdermal medication therapy, meaning an herbal preparation applied to the skin, has no CIDP research behind it, and should not be used over broken skin or numb areas where irritation may go unnoticed.

What the research shows

There is no evidence for herbal medicine in CIDP. The review authors noted that some studies reported improved pain, nerve function and quality of life in other neuropathies, and that more studies are needed.[16]

Safety and herb-drug interactions

This is the most important section for this condition, because many people with CIDP take corticosteroids or immune-suppressing drugs. Herbs and prescription drugs can interact. Published cases include St John's wort lowering blood levels of cyclosporin and tacrolimus, with organ rejection reported when cyclosporin levels fell.[17] Herbs described as immune-stimulating may also work against the purpose of your treatment, so each herb must be reviewed with your prescriber.

Herbal and dietary supplements account for about 20% of drug-induced liver injury cases in the United States, which matters if you take azathioprine, methotrexate or other drugs that affect the liver.[18] In one study, about one fifth of Ayurvedic medicines bought online contained detectable lead, mercury or arsenic.[19] Heavy metals can themselves injure nerves, so use only tested products prescribed individually, and tell us if you are pregnant or breastfeeding or have liver or kidney disease.

Translating traditional medicine into modern biological language

This is interpretation, not equivalence. Chinese medicine may describe limb weakness and numbness through patterns such as qi and blood deficiency, blood stasis or obstruction in the channels. Researchers instead study immune signaling, nerve conduction and the nervous system's role in pain, and some propose that acupuncture acts on the nervous, hormonal and immune systems.[13]

In Ayurveda, aggravated Vata describes numbness, weakness and pain. It might loosely parallel nerve dysfunction, but no study has shown that a dosha corresponds to a biological process or that either framework changes demyelination.

How this care fits with your medical care

Supportive care here is complementary. CIDP needs specialist treatment, and we ask that you are under a physician's care for it and that your treating team knows you are receiving complementary care. Do not stop or change prescribed immunoglobulin, steroids, immune-suppressing drugs or physical therapy without your prescriber.

We do not diagnose or manage the disease. Please bring your diagnosis, nerve conduction results, a full list of medicines and supplements, and the names of your specialists. Report new or worsening symptoms to your neurologist rather than waiting for a visit with us.

When to seek urgent medical care

Rapidly worsening weakness may signal a relapse or another serious nerve problem, and needs prompt assessment.

  • Weakness that is spreading or worsening over hours to days
  • Trouble breathing, swallowing or speaking, or a weak cough
  • Difficulty walking, repeated falls or inability to stand
  • New loss of bladder or bowel control
  • Fever, spreading redness or other signs of infection while on immune-suppressing treatment

For trouble breathing, trouble swallowing or any emergency, call 911 or go to the nearest emergency department.

Frequently asked questions

What is Chronic Inflammatory Demyelinating Polyneuropathy?

Chronic inflammatory demyelinating polyneuropathy, or CIDP, is a rare, treatable immune-mediated disease of the peripheral nerves. The immune system damages the myelin covering of the nerves, which causes weakness, numbness and tingling over at least 8 weeks. It is related to Guillain-Barré syndrome but follows a slower, longer course and needs treatment from a neurologist.

Can acupuncture help people with Chronic Inflammatory Demyelinating Polyneuropathy?

No studies of acupuncture in CIDP were found, so we cannot say it helps the disease. Acupuncture has been studied for nerve pain, fatigue and sleep in other groups, with limited or low-quality evidence for nerve pain. It is considered only as supportive care for comfort, alongside your neurologist, never in place of treatment.

Are Ayurvedic or herbal medicines safe with my CIDP medications?

Not automatically. Some herbs change how prescription drugs are processed, and some may work against immune-suppressing treatment. No studies of Ayurvedic or herbal medicine in CIDP were found. Anything we consider would be chosen individually and reviewed against your medicine list, ideally with your neurologist aware.

Can I stop my immunoglobulin or steroids if I have acupuncture?

No. Acupuncture, Ayurveda and herbal medicine do not replace treatment for CIDP. Stopping or changing immunoglobulin, steroids or immune-suppressing drugs without your neurologist can allow nerve damage to progress. Talk with your prescriber before any change, and keep all specialist appointments.

How soon might I notice a change in comfort?

It varies, and no result can be promised. Because there are no studies in CIDP, we cannot give an expected timeline. A review of acupuncture for sleep problems found benefit after about three weeks. We would reassess after a short course of visits to see whether supportive care is helping.

Does insurance cover acupuncture for CIDP?

It may. Netra Integrative Health Clinic accepts most major insurance plans that include out-of-network acupuncture benefits, for example Aetna, Blue Cross Blue Shield, Cigna and UnitedHealthcare, and offers a free benefits check. HSA and FSA cards and CareCredit are also accepted. Call (908) 402-7301 to ask about your plan.

References

  1. Gogia B, Rocha Cabrero F, Khan Suheb MZ, et al. Chronic Inflammatory Demyelinating Polyradiculoneuropathy. StatPearls [Internet]. 2024. PMID 33085396. StatPearls chapter on CIDP: an immune-mediated disorder of peripheral nerves and roots, with symmetric weakness, a course of at least 8 weeks, and its relationship to Guillain-Barré syndrome.
  2. Broers MC, Bunschoten C, Nieboer D, et al. Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2019;52(3-4):161-172. PMID 30669140. Meta-analysis of 11 studies estimating CIDP prevalence at about 2.8 per 100,000 and incidence at about 0.33 per 100,000 per year, varying with diagnostic criteria.
  3. Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. Eur J Neurol. 2021;28(11):3556-3583. PMID 34327760. European Academy of Neurology and Peripheral Nerve Society guideline on CIDP diagnosis and treatment: IVIg or corticosteroids first, plasma exchange next, maintenance options, and pain management advice.
  4. Bunschoten C, Jacobs BC, Van den Bergh PYK, et al. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol. 2019;18(8):784-794. PMID 31076244. Lancet Neurology review of CIDP diagnosis and treatment, noting it is treatable, often needs years of maintenance therapy, and may involve nodal antibodies in poor responders.
  5. De León-Muñoz A, Ávila-Gandía V, Andreu-Caravaca L. Impact of Physical Exercise Programs on Fatigue and Functional Capacity in People With Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review. Arch Phys Med Rehabil. 2026;107(5):1067-1078. PMID 41038424. Systematic review of 13 studies (173 people, 37 with CIDP) finding that multicomponent exercise programs appeared to improve fatigue and function in Guillain-Barré syndrome and CIDP.
  6. White CM, van Doorn PA, Garssen MP, et al. Interventions for fatigue in peripheral neuropathy. Cochrane Database Syst Rev. 2014;2014(12):CD008146. PMID 25519471. Cochrane review of 3 trials of treatments for fatigue in peripheral neuropathy, finding little or uncertain benefit and no evidence for other interventions.
  7. Humphrey MB, Russell L, Danila MI, et al. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol. 2023;75(12):2088-2102. PMID 37845798. 2022 American College of Rheumatology guideline on preventing and treating glucocorticoid-induced osteoporosis in people on steroids for more than three months.
  8. Ju ZY, Wang K, Cui HS, et al. Acupuncture for neuropathic pain in adults. Cochrane Database Syst Rev. 2017;12(12):CD012057. PMID 29197180. Cochrane review of 6 small trials (462 people) of acupuncture for neuropathic pain, concluding the evidence is very low quality and insufficient to support or refute benefit.
  9. Dimitrova A, Murchison C, Oken B. Acupuncture for the Treatment of Peripheral Neuropathy: A Systematic Review and Meta-Analysis. J Altern Complement Med. 2017;23(3):164-179. PMID 28112552. Systematic review of 15 acupuncture studies in neuropathies of various causes, with benefit in diabetic neuropathy, Bell's palsy and carpal tunnel syndrome and insufficient evidence in idiopathic neuropathy.
  10. Zhou L, Wu T, Zhong Z, et al. Acupuncture for painful diabetic peripheral neuropathy: a systematic review and meta-analysis. Front Neurol. 2023;14:1281485. PMID 38046594. Meta-analysis of 25 trials (1,561 people) finding acupuncture added to conventional care eased pain in painful diabetic neuropathy, with limitations noted.
  11. Zhang Q, Gong J, Dong H, et al. Acupuncture for chronic fatigue syndrome: a systematic review and meta-analysis. Acupunct Med. 2019;37(4):211-222. PMID 31204859. Meta-analysis of 16 studies (1,346 people) of acupuncture for chronic fatigue syndrome, finding favorable effects over sham but mostly low-quality studies and no firm conclusion.
  12. Kim SA, Lee SH, Kim JH, et al. Efficacy of Acupuncture for Insomnia: A Systematic Review and Meta-Analysis. Am J Chin Med. 2021;49(5):1135-1150. PMID 34049475. Meta-analysis of 24 trials of acupuncture for insomnia, finding better sleep scores than medication, with benefit seen after about three weeks.
  13. Ding SS, Hong SH, Wang C, et al. Acupuncture modulates the neuro-endocrine-immune network. QJM. 2014;107(5):341-5. PMID 24106314. Review proposing that acupuncture's effects may work through the neuro-endocrine-immune network, presented as a hypothesis.
  14. Bäumler P, Zhang W, Stübinger T, et al. Acupuncture-related adverse events: systematic review and meta-analyses of prospective clinical studies. BMJ Open. 2021;11(9):e045961. PMID 34489268. Systematic review of 21 prospective studies finding minor acupuncture reactions in about 9 percent of patients and serious events in about 1 per 10,000.
  15. Arumugam V, Vijayakumar V, Balakrishnan A, et al. Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysis. Explore (NY). 2024;20(6):103062. PMID 39348746. Meta-analysis of 9 trials (558 people) finding ashwagandha lowered stress, anxiety scores and cortisol versus placebo, with mild to moderate adverse events.
  16. Ebrahimi F, Farzaei MH, Bahramsoltani R, et al. Plant-derived medicines for neuropathies: a comprehensive review of clinical evidence. Rev Neurosci. 2019;30(6):671-684. PMID 30768427. Review of 22 clinical studies of plant-derived medicines in neuropathies, with most evidence for cannabis, linseed oil, capsaicin and a Japanese formula, and one trial each for turmeric and chamomile.
  17. Hu Z, Yang X, Ho PC, et al. Herb-drug interactions: a literature review. Drugs. 2005;65(9):1239-82. PMID 15916450. Literature review of herb-drug interactions, including St John's wort lowering cyclosporin and tacrolimus levels, with organ rejection reported.
  18. Navarro VJ, Khan I, Björnsson E, et al. Liver injury from herbal and dietary supplements. Hepatology. 2017;65(1):363-373. PMID 27677775. Hepatology review of liver injury from herbal and dietary supplements, which account for about 20% of drug-induced liver injury in the US.
  19. Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 2008;300(8):915-23. PMID 18728265. JAMA study finding detectable lead, mercury or arsenic in about one fifth of Ayurvedic medicines purchased over the Internet.

This page is for general education and is not medical advice. Acupuncture, Ayurvedic medicine and herbal medicine are complementary therapies; they do not replace diagnosis or treatment by your physician. Do not stop or change prescribed treatment without talking to your prescriber. In an emergency call 911.

South Plainfield, New Jersey

Chronic Inflammatory Demyelinating Polyneuropathy care near you

Netra Integrative Health Clinic is at 5001 Hadley Rd, Ste 210, South Plainfield, NJ 07080, a short drive from Edison, Piscataway, Plainfield, Metuchen, Dunellen and Middlesex. We are open Monday to Friday, 10:00 AM to 8:00 PM, and see patients in person.

Care is provided by Dr. Saikumar Gandapodi, DAOM, Dipl. OM, L.Ac., a board certified and New Jersey licensed acupuncturist. Most major insurance plans with out-of-network acupuncture benefits are accepted, and we can check your benefits before your first visit.

Autoimmune & Inflammation

Related conditions

All in
Autoimmune & Inflammation
→
Board Certified and State Licensed Practitioner
NCCAOMDiplomate of Oriental MedicineNational Ayurvedic Medical Association